Par Pharmaceutical Companies (PRX)
Par Pharmaceutical Companies Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 30, 2012 | 37.26 | 37.93 | 36.47 | 37.01 | 1138380 |
| May 29, 2012 | 41.05 | 41.11 | 36.98 | 37.70 | 1714723 |
| May 25, 2012 | 39.55 | 41.61 | 39.43 | 40.88 | 333016 |
| May 24, 2012 | 39.48 | 39.69 | 39.19 | 39.54 | 245284 |
| May 23, 2012 | 39.83 | 40.15 | 38.94 | 39.61 | 129685 |
| May 22, 2012 | 40.00 | 40.55 | 39.82 | 40.15 | 255332 |
| May 21, 2012 | 39.24 | 40.61 | 39.13 | 40.02 | 339121 |
| May 18, 2012 | 39.89 | 39.92 | 38.90 | 39.06 | 448600 |
| May 17, 2012 | 40.31 | 40.55 | 39.94 | 39.94 | 272844 |
| May 16, 2012 | 40.86 | 40.90 | 40.27 | 40.34 | 229464 |
| May 15, 2012 | 41.12 | 41.68 | 40.56 | 40.81 | 234640 |
| May 14, 2012 | 40.44 | 41.64 | 40.38 | 41.20 | 288231 |
| May 11, 2012 | 40.32 | 41.17 | 40.32 | 40.91 | 184162 |
| May 10, 2012 | 41.66 | 41.66 | 40.45 | 40.72 | 383600 |
| May 9, 2012 | 41.50 | 42.61 | 40.75 | 41.25 | 364154 |
| May 8, 2012 | 42.11 | 42.21 | 41.23 | 42.08 | 407390 |
| May 7, 2012 | 41.64 | 42.45 | 41.62 | 42.16 | 196872 |
| May 4, 2012 | 42.30 | 42.36 | 41.51 | 41.65 | 314618 |
| May 3, 2012 | 42.50 | 42.77 | 42.35 | 42.56 | 310477 |
| May 2, 2012 | 42.00 | 42.80 | 41.75 | 42.58 | 468524 |
| May 1, 2012 | 42.08 | 42.67 | 42.05 | 42.15 | 557144 |
| April 30, 2012 | 42.06 | 42.37 | 41.89 | 42.34 | 514253 |
| April 27, 2012 | 41.54 | 42.25 | 41.50 | 42.00 | 242031 |
| April 26, 2012 | 41.62 | 41.75 | 41.40 | 41.54 | 320480 |
| April 25, 2012 | 41.00 | 41.62 | 40.81 | 41.55 | 408274 |
| April 24, 2012 | 40.54 | 40.94 | 40.14 | 40.94 | 263398 |
| April 23, 2012 | 40.29 | 40.44 | 39.53 | 40.40 | 292593 |
| April 20, 2012 | 40.83 | 41.30 | 40.50 | 41.12 | 263263 |
| April 19, 2012 | 40.50 | 40.83 | 39.79 | 40.20 | 310782 |
| April 18, 2012 | 40.37 | 40.87 | 39.90 | 40.45 | 207589 |
| April 17, 2012 | 40.04 | 40.99 | 40.04 | 40.57 | 201897 |
| April 16, 2012 | 40.20 | 40.36 | 39.51 | 39.82 | 247551 |
| April 13, 2012 | 40.27 | 40.50 | 39.68 | 40.12 | 227330 |
| April 12, 2012 | 39.62 | 40.72 | 39.62 | 40.44 | 288678 |
| April 11, 2012 | 40.02 | 40.07 | 39.42 | 39.69 | 369400 |
| April 10, 2012 | 40.62 | 40.84 | 39.50 | 39.59 | 440562 |
| April 9, 2012 | 40.20 | 41.00 | 40.01 | 40.55 | 289912 |
| April 5, 2012 | 39.50 | 41.98 | 39.45 | 40.92 | 497527 |
| April 4, 2012 | 39.20 | 39.33 | 38.97 | 39.32 | 271644 |
| April 3, 2012 | 39.64 | 40.12 | 39.39 | 39.62 | 307767 |
| April 2, 2012 | 38.66 | 39.82 | 38.56 | 39.80 | 366799 |
| March 30, 2012 | 39.10 | 39.42 | 38.66 | 38.73 | 322734 |
| March 29, 2012 | 38.14 | 38.87 | 38.12 | 38.85 | 304873 |
| March 28, 2012 | 38.75 | 38.92 | 38.32 | 38.55 | 309524 |
| March 27, 2012 | 38.45 | 38.65 | 38.38 | 38.51 | 240032 |
| March 26, 2012 | 37.30 | 38.50 | 37.17 | 38.42 | 307021 |
| March 23, 2012 | 36.73 | 37.26 | 36.66 | 37.18 | 175753 |
| March 22, 2012 | 36.07 | 36.82 | 36.07 | 36.74 | 231486 |
| March 21, 2012 | 36.41 | 37.12 | 36.41 | 36.47 | 254389 |
| March 20, 2012 | 36.60 | 36.83 | 35.96 | 36.42 | 244522 |
PRX News
Barclays Cuts Estimates on Par Pharmaceutical (PRX); Removing Lovaza Contribution From Model
May 31, 2:11PM Street Insider
May 31, 2:11PM Street Insider
Teva Pharmaceutical Inds, VeriFone Systems Among Stocks Down on Above-average Volume Tuesday
May 29, 4:34PM Fox Business
May 29, 4:34PM Fox Business
$PRX Mentioned more than normal on StockTwits - Currently at 8 x average daily social activity
about 2 days ago by TradeIdeasQuant
about 2 days ago by TradeIdeasQuant
$AMRN up following news that $Teva and $PRX lost a bid to sell the generic form of $GSK Lovaza. http://stks.co/41F0
about 2 days ago by abubnic
about 2 days ago by abubnic
Teva (TEVA), Par Pharma (NPRX) said to lose bid to sell the generic form of Glaxo's (GSK) Lovaza
May 29, 3:20PM Street Insider
May 29, 3:20PM Street Insider
RT @TraderRadar $AAPL $NFLX $PRX Keep these on your radar for higher prices next week// $NFLX based on what evidence??
about 6 days ago by lipong23
about 6 days ago by lipong23
$AAPL $NFLX $PRX Keep these on your radar for higher prices next week
about 6 days ago by TraderRadar
about 6 days ago by TraderRadar
@TraderRadar Like $PRX - should keep moving after pull back to $39 area
about 6 days ago by OMillionaires
about 6 days ago by OMillionaires
UBS Maintains a 'Buy' on Par Pharmaceutical (PRX); Comments From Conference Call
May 09, 12:21PM Street Insider
May 09, 12:21PM Street Insider
Listen to $PRX Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3iVK
about 23 days ago by earningscast
about 23 days ago by earningscast
Also sold my $HMSY on weakness. Picked up shares of $PRX Friday. Any thoughts?
about 40 days ago by robertfreedland
about 40 days ago by robertfreedland
Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Healthy Deal with Handa
Apr 20, 9:46AM Street Insider
Apr 20, 9:46AM Street Insider
Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S.
Apr 19, 3:05PM Benzinga
Apr 19, 3:05PM Benzinga
Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012
Apr 09, 9:00AM PR Newswire
Apr 09, 9:00AM PR Newswire
$PRX is 5.0% up since open on unusual high volume and 5.5% up since close.
about 56 days ago by TradeBot
about 56 days ago by TradeBot
$WCG $CL $SJM $PRX Hit 52-Week Highs http://stks.co/39sz My story via @TheStreet #52WeekHigh
about 62 days ago by azendrian
about 62 days ago by azendrian
$PRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/39RA
about 62 days ago by MarketBrief
about 62 days ago by MarketBrief
Horizon Pharma (HZNP) Files Patent Infringement Suit Against Par Pharma (PRX) Over DUEXIS Tabs
Mar 28, 4:30PM Street Insider
Mar 28, 4:30PM Street Insider
$PRX forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/33Pn
about 69 days ago by RecogniaEvents
about 69 days ago by RecogniaEvents
Impressive development programs, partnerships and product launch prep make IntelGenX look like a solid bet at these prices
Mar 23, 8:34AM Thomson Reuters ONE
Mar 23, 8:34AM Thomson Reuters ONE
$PRX forms bearish "Triple Top" chart pattern. http://stks.co/2epQ
about 90 days ago by RecogniaEvents
about 90 days ago by RecogniaEvents
Listen to $PRX Q4 2011 earnings call - live at 09:00 AM, ondemand after - http://stks.co/2af5
about 93 days ago by earningscast
about 93 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PRX | 35.84 | -1.17 | -3.16% | 1.353B |
| PRWTD | 1.51 | -0.04 | -2.58% | |
| PRWT | 1.51 | -0.04 | -2.58% | 15.15M |
| PRU | 46.45 | -0.20 | -0.43% | 21.92B |
| PLL | 55.65 | -0.76 | -1.35% | 6.510B |
| PLG | 1.19 | -0.01 | -0.83% | 213.11M |
| PLFE | 8.84 | +0.04 | +0.45% | 260.30M |
| PLD | 32.00 | +0.21 | +0.66% | 14.62B |
| PLCM | 11.45 | -0.13 | -1.12% | 2.055B |
| PATR | 20.39 | -0.73 | -3.46% | 189.83M |